Blonder Tongue Laboratories, Inc. (BDRLQ)

BDRLQ Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	18.12	15.75	16.38	19.84	21.71
Revenue Growth (YoY)	14.99%	-3.82%	-17.45%	-8.59%	-6.77%
Cost of Revenue	12.65	9.9	13.36	16.41	13.29
Gross Profit	5.46	5.86	3.02	3.43	8.42
Selling, General & Admin	5.82	6.23	7.61	8.01	6.7
Research & Development	1.78	2.59	2.52	3.07	2.58
Operating Expenses	7.59	8.82	10.13	11.07	9.27
Operating Income	-2.13	-2.96	-7.11	-7.64	-0.85
Interest Expense	-0.79	-0.51	-0.35	-0.26	-0.56
EBT Excluding Unusual Items	-2.92	-3.47	-7.46	-7.9	-1.42
Gain (Loss) on Sale of Assets	-	-	-	7.18	-
Other Unusual Items	-	3.57	-	-	-
Pretax Income	-2.92	0.1	-7.46	-0.73	-1.42
Income Tax Expense	-	0.02	0.02	0.02	-0.08
Net Income	-2.92	0.08	-7.47	-0.74	-1.34
Net Income to Common	-2.92	0.08	-7.47	-0.74	-1.34
Shares Outstanding (Basic)	13	12	10	10	9
Shares Outstanding (Diluted)	13	12	10	10	9
Shares Change (YoY)	9.30%	22.76%	3.07%	7.91%	8.67%
EPS (Basic)	-0.22	0.01	-0.76	-0.08	-0.15
EPS (Diluted)	-0.22	0.01	-0.76	-0.08	-0.15
Free Cash Flow	-1.43	-1.2	-3.38	-6.8	0.51
Free Cash Flow Per Share	-0.11	-0.10	-0.34	-0.71	0.06
Gross Margin	30.16%	37.18%	18.43%	17.29%	38.78%
Operating Margin	-11.76%	-18.79%	-43.43%	-38.51%	-3.93%
Profit Margin	-16.12%	0.53%	-45.63%	-3.74%	-6.17%
Free Cash Flow Margin	-7.89%	-7.60%	-20.62%	-34.28%	2.33%
EBITDA	-2.01	-2.62	-6.78	-7.25	-0.33
EBITDA Margin	-11.07%	-16.63%	-41.41%	-36.56%	-1.53%
D&A For EBITDA	0.13	0.34	0.33	0.39	0.52
EBIT	-2.13	-2.96	-7.11	-7.64	-0.85
EBIT Margin	-11.76%	-18.79%	-43.43%	-38.51%	-3.93%
Effective Tax Rate	-	15.15%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.